What Is a Day 14 Bone Marrow Biopsy in AML Treatment?

The Day 14 bone marrow biopsy is a standard test performed about halfway through your initial hospital stay for acute myeloid leukemia (AML) treatment. Its main purpose is to check if your first round of chemotherapy has successfully emptied your bone marrow of leukemia cells ^[1].

Checking for an Empty Bone Marrow

During your initial treatment phase (called induction), the goal is to quickly destroy as many leukemia cells as possible ^[1]. By around day 14 of your hospital stay, the chemotherapy has had time to do its heaviest work. Doctors do a bone marrow biopsy at this specific point to get an early look at how well the treatment is working before your healthy blood cells start to grow back ^[2].

When your care team looks at the Day 14 biopsy results, they are hoping to see a state called aplasia ^[2]. This is a medical term that simply means your bone marrow looks “empty.” While hearing that your bone marrow is empty might sound concerning, it is actually the desired result at this stage ^[2]. It means the chemotherapy has successfully cleared out the leukemia cells (often called blasts) ^[2]. Once the marrow is empty, it gives your healthy blood-forming cells the room they need to eventually grow back and recover.

What Happens if Leukemia Cells Are Still Present?

If the Day 14 biopsy shows that leukemia cells are still present, it means the first round of chemotherapy did not completely clear the marrow ^[3]. Your medical team uses this early information to make immediate decisions about your treatment plan ^[4]. In many standard protocols, if a significant number of blasts are still present, doctors may need to administer a second round of chemotherapy right away (often called re-induction) to try and clear the remaining disease ^[4][3]. While hearing you might need more chemotherapy can be terrifying, needing a second round is a relatively common scenario in AML treatment and does not mean the overall treatment strategy has failed. It will, however, usually extend your initial hospital stay.

Sometimes, doctors use newer strategies. Depending on your specific type of AML and the medications you are receiving, your care team might decide that waiting and watching your blood counts closely is safer than immediately giving more chemotherapy ^[5]. In a “watch and wait” scenario, you will typically stay in the hospital so doctors can safely monitor you while waiting for healthy blood cells to recover.

During the biopsy review, they may also use highly sensitive laboratory tests like flow cytometry to look for MRD (Minimal or Measurable Residual Disease) ^[6][7]. These tests search for tiny amounts of leftover leukemia cells that a standard microscope might miss ^[6].

Waiting for Results

Waiting for the results can be agonizing. Different parts of the biopsy take different amounts of time to process:

Ask your doctor exactly when to expect each piece of the puzzle so you aren’t waiting in suspense.

Coping with Another Biopsy

Because you have already had at least one bone marrow biopsy to diagnose your AML, you likely know what the procedure involves ^[10]. The Day 14 biopsy is done the same way, usually taking a sample from the back of your hip bone. Since you are already dealing with the side effects of chemotherapy, it is completely normal to feel anxious or physically exhausted by the prospect of another test.

You do not have to just endure the pain. There are specific pain and anxiety management options you can advocate for:

• Anti-anxiety medications: You can ask for an oral pill (like lorazepam) to take before the procedure to calm your nerves.
• Conscious sedation: Some hospitals offer IV sedation (sometimes called “twilight sleep”) so you are relaxed and largely unaware during the procedure.

Unless you are receiving heavy sedation, you typically do not need to fast beforehand, and your physical recovery from this procedure will be very similar to your first biopsy.